Skipper LM - Search Results

1

Genomic investigation of alpha-synuclein multiplication and parkinsonism.

Ross OA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton FA, Nishioka K, Fuchs J, Gasser T, Maraganore DM, Adler CH, Larvor L, Chartier-Harlin MC, Nilsson C, Langston JW, Gwinn K, Hattori N, Farrer MJ. Ross OA, et al. Among authors: skipper lm. Ann Neurol. 2008 Jun;63(6):743-50. doi: 10.1002/ana.21380. Ann Neurol. 2008. PMID: 18571778 Free PMC article.

2

Linkage disequilibrium and association of MAPT H1 in Parkinson disease.

Skipper L, Wilkes K, Toft M, Baker M, Lincoln S, Hulihan M, Ross OA, Hutton M, Aasly J, Farrer M. Skipper L, et al. Am J Hum Genet. 2004 Oct;75(4):669-77. doi: 10.1086/424492. Epub 2004 Aug 3. Am J Hum Genet. 2004. PMID: 15297935 Free PMC article.

3

alpha-Synuclein promoter confers susceptibility to Parkinson's disease.

Pals P, Lincoln S, Manning J, Heckman M, Skipper L, Hulihan M, Van den Broeck M, De Pooter T, Cras P, Crook J, Van Broeckhoven C, Farrer MJ. Pals P, et al. Ann Neurol. 2004 Oct;56(4):591-5. doi: 10.1002/ana.20268. Ann Neurol. 2004. PMID: 15455394

4

Fine-mapping and candidate gene investigation within the PARK10 locus.

Haugarvoll K, Toft M, Skipper L, Heckman MG, Crook JE, Soto A, Ross OA, Hulihan MM, Kachergus JM, Sando SB, White LR, Lynch T, Gibson JM, Uitti RJ, Wszolek ZK, Aasly JO, Farrer MJ. Haugarvoll K, et al. Eur J Hum Genet. 2009 Mar;17(3):336-43. doi: 10.1038/ejhg.2008.187. Epub 2008 Oct 15. Eur J Hum Genet. 2009. PMID: 18854859 Free PMC article.

5

Identification of the human ubiquitin specific protease 31 (USP31) gene: structure, sequence and expression analysis.

Lockhart PJ, Hulihan M, Lincoln S, Hussey J, Skipper L, Bisceglio G, Wilkes K, Farrer MJ. Lockhart PJ, et al. DNA Seq. 2004 Feb;15(1):9-14. doi: 10.1080/10855660310001638197. DNA Seq. 2004. PMID: 15354349

6

Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations.

Wiley J, Lynch T, Lincoln S, Skipper L, Hulihan M, Gosal D, Bisceglio G, Kachergus J, Hardy J, Farrer MJ. Wiley J, et al. Mov Disord. 2004 Jun;19(6):677-81. doi: 10.1002/mds.10703. Mov Disord. 2004. PMID: 15197707

7

Analysis of LRRK2 functional domains in nondominant Parkinson disease.

Skipper L, Shen H, Chua E, Bonnard C, Kolatkar P, Tan LC, Jamora RD, Puvan K, Puong KY, Zhao Y, Pavanni R, Wong MC, Yuen Y, Farrer M, Liu JJ, Tan EK. Skipper L, et al. Neurology. 2005 Oct 25;65(8):1319-21. doi: 10.1212/01.wnl.0000180517.70572.37. Neurology. 2005. PMID: 16247070

8

Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family.

Wider C, Skipper L, Solida A, Brown L, Farrer M, Dickson D, Wszolek ZK, Vingerhoets FJ. Wider C, et al. Parkinsonism Relat Disord. 2008 Aug;14(6):465-70. doi: 10.1016/j.parkreldis.2007.11.013. Epub 2008 Mar 14. Parkinsonism Relat Disord. 2008. PMID: 18342564

9

The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients.

Tan EK, Shen H, Tan LC, Farrer M, Yew K, Chua E, Jamora RD, Puvan K, Puong KY, Zhao Y, Pavanni R, Wong MC, Yih Y, Skipper L, Liu JJ. Tan EK, et al. Neurosci Lett. 2005 Aug 26;384(3):327-9. doi: 10.1016/j.neulet.2005.04.103. Neurosci Lett. 2005. PMID: 15955629 Clinical Trial.

10

The tau H1 haplotype is associated with Parkinson's disease in the Norwegian population.

Farrer M, Skipper L, Berg M, Bisceglio G, Hanson M, Hardy J, Adam A, Gwinn-Hardy K, Aasly J. Farrer M, et al. Neurosci Lett. 2002 Apr 5;322(2):83-6. doi: 10.1016/s0304-3940(02)00106-4. Neurosci Lett. 2002. PMID: 11958849

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

24 results

Search Page